[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 341 Introduced in House (IH)]
<DOC>
116th CONGRESS
1st Session
H. RES. 341
Expressing support for the designation of May as ``National Bladder
Cancer Awareness Month''.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
May 1, 2019
Mr. Cartwright (for himself and Ms. Norton) submitted the following
resolution; which was referred to the Committee on Energy and Commerce
_______________________________________________________________________
RESOLUTION
Expressing support for the designation of May as ``National Bladder
Cancer Awareness Month''.
Whereas more than 500,000 families in the United States live with bladder
cancer;
Whereas more than 80,000 people are expected to be diagnosed with bladder cancer
and over 17,000 will die due to the disease in 2019 alone;
Whereas bladder cancer affects people of all ages and backgrounds and is among
the top 10 cancers with the highest incidence rates in the United
States;
Whereas bladder cancer is known as one of the most expensive cancers to treat on
a per patient basis with a recurrence rate of approximately 50 to 80
percent, requiring lifelong surveillance;
Whereas bladder cancer symptoms, such as blood in the urine, are easily
recognized, however, many are unaware of the threat of bladder cancer,
often prolonging time to diagnosis;
Whereas if diagnosed early, bladder cancer is treatable;
Whereas military veterans are twice as likely as non-veterans to be diagnosed
with bladder cancer;
Whereas women are often diagnosed at a later stage in the development of bladder
cancer, and when diagnosed at the same stage as men, women have a worse
prognosis;
Whereas if diagnosis and treatment are delayed, the life expectancy of an
individual with bladder cancer decreases;
Whereas the quality of life of a person with bladder cancer will depend on
future treatment and diagnosis developments, which will rely on research
advancements;
Whereas there have been few new treatments developed for bladder cancer in more
than 20 years;
Whereas research advancements for bladder cancer are limited by lack of
awareness about the disease within the medical community and general
public;
Whereas increased awareness will promote early diagnosis and increase chances of
survival;
Whereas increased awareness will bolster public support of the disease and thus
increase funding for innovative research and the development of new
treatment options and diagnostic tools;
Whereas traditionally, throughout May, survivors, caregivers, and loved ones
walk together throughout the United States to raise awareness of bladder
cancer;
Whereas the Bladder Cancer Advocacy Network and its community of patients,
caregivers, and specialists seek to foster a community of hope and
support, fund and conduct research for innovative treatments and
diagnostic tools, and increase public awareness and understanding of
bladder cancer; and
Whereas May would be an appropriate month to designate as ``National Bladder
Cancer Awareness Month'': Now, therefore, be it
Resolved, That the House of Representatives--
(1) supports the designation of ``National Bladder Cancer
Awareness Month'';
(2) supports the goals and ideals of ``National Bladder
Cancer Awareness Month''; and
(3) calls on the people of the United States, interested
groups, and affected persons to--
(A) promote awareness of bladder cancer and to
foster understanding of the impact of the disease on
patients and their families and caregivers;
(B) take an active role in the fight to end bladder
cancer; and
(C) observe ``National Bladder Cancer Awareness
Month'' with appropriate ceremonies and activities.
<all>